Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
US Army
Chubb
US Department of Justice
Chinese Patent Office
Baxter
Fish and Richardson
Mallinckrodt
Colorcon

Generated: November 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018276

« Back to Dashboard

NDA 018276 describes XANAX, which is a drug marketed by Pharmacia And Upjohn and is included in two NDAs. It is available from seven suppliers. Additional details are available on the XANAX profile page.

The generic ingredient in XANAX is alprazolam. There are fifteen drug master file entries for this compound. Fifty-one suppliers are listed for this compound. Additional details are available on the alprazolam profile page.
Summary for 018276
Tradename:XANAX
Applicant:Pharmacia And Upjohn
Ingredient:alprazolam
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 018276
Ingredient-typeBenzodiazepines
Medical Subject Heading (MeSH) Categories for 018276
Suppliers and Packaging for NDA: 018276
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
XANAX alprazolam TABLET;ORAL 018276 NDA Pharmacia and Upjohn Company LLC 0009-0029 0009-0029-01 100 TABLET in 1 BOTTLE (0009-0029-01)
XANAX alprazolam TABLET;ORAL 018276 NDA Pharmacia and Upjohn Company LLC 0009-0029 0009-0029-02 500 TABLET in 1 BOTTLE (0009-0029-02)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength0.25MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength0.5MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength1MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Expired US Patents for NDA 018276

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn XANAX alprazolam TABLET;ORAL 018276-003 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Pharmacia And Upjohn XANAX alprazolam TABLET;ORAL 018276-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Pharmacia And Upjohn XANAX alprazolam TABLET;ORAL 018276-002 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Pharmacia And Upjohn XANAX alprazolam TABLET;ORAL 018276-004 Nov 27, 1985 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Johnson and Johnson
Accenture
Deloitte
Colorcon
Cantor Fitzgerald
Harvard Business School
Chubb
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.